Notably, seven out of 29 cases had SET overexpressed, and three out of those seven SET-overexpressing cases showed a concomitant miR-199b downregulation, which suggests that this alteration is a contributing mechanism to deregulate SET in early-stage CRC [39]. Here, SET is linked to colorectal carcinoma.